According to reports, Belanger is a believer in Ocular mainly on the potential of its investigational Axpaxli, a drug that ...

One of the biggest mistakes investors make when trading their portfolios and putting capital to work is staying away from discounts. It is human nature to avoid a stock chart that has been down and to ...

The semiconductor industry has been the center of attention for investors looking to get into the United States technology ...